Health

Business Wire Australia and New Zealand

Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®? (Tivozanib) for Patients with Advanced Renal Cell Carcinoma

22-Oct-2018 7:01 PM
HEMEL HEMPSTEAD, England--(BUSINESS WIRE)--EUSA Pharma (EUSA) welcomes the news that FOTIVDA®? (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell

Business Wire Australia and New Zealand

Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

22-Oct-2018 4:23 PM
Additional subgroup analysis shows subcutaneous formulation of vedolizumab achieves significantly higher clinical remission rates to placebo in anti-TNFa-naïve patients   OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limit

Business Wire Australia and New Zealand

Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC

21-Oct-2018 8:23 PM
GioTag is the first global, real-world study to evaluate the sequencing of targeted treatments in patients with the most common acquired treatment resistance mutation1 Results published today in Future Oncology1 INGELHE

Business Wire Australia and New Zealand

Edogawa Niche Prize 2018 to Be Awarded to Prof. James Till for Stem Cell Discovery

19-Oct-2018 4:46 PM
NCRM & Edogawa Hospital to jointly award it as a part of NCRM NICHE in Tokyo, Japan Prof. James Till after the 2018 Edogawa NICHE Prize Ceremony with Prof. Levy, Prof. Humar & Dr. Abraham (Photo: Business Wire) TOKYO--(BUSINESS

Business Wire Australia and New Zealand

Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc

18-Oct-2018 6:47 PM
  OSAKA, Japan--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Takeda Ph

Business Wire Australia and New Zealand

AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement of Commercial Shipping

18-Oct-2018 11:09 AM
Multiple U.S. burn centers incorporating RECELL System into their practices in advance of national U.S. market launch   VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH, OTCQX: AVMXY), a glo

Business Wire Australia and New Zealand

Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health

17-Oct-2018 4:20 PM
Ferring will access Evotec’s integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates Evotec will apply its drug discovery platform to design novel and efficacious treat

Business Wire Australia and New Zealand

Brightree Launches First Patient App for HME

17-Oct-2018 9:41 AM
Patient Hub extends the reach of post-acute providers with secure, automated patient engagement platform ATLANTA--(BUSINESS WIRE)--Brightree®, the leading provider of cloud-based software to help post-acute care companies improve

Business Wire Australia and New Zealand

AVITA Medical Announces Medical Education Symposium and Presentation of RECELL® System Pivotal Trial Results at U.S. Midwest Region Burn Conference

16-Oct-2018 10:55 AM
Medical education symposium is designed to train U.S. physicians in use of RECELL System   VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medici

Business Wire Australia and New Zealand

AirFit F30, ResMed’s First Minimal-Contact Full Face CPAP Mask, Now Available in the U.S., Canada

16-Oct-2018 10:10 AM
Nearly 2 to 1 patients prefer AirFit F30 over the current minimal-contact full face market leader   AirFit F30 full face CPAP mask: Side View (Photo: Business Wire) SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD)

Business Wire Australia and New Zealand

Results from Pradaxa® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke Congress

15-Oct-2018 6:20 PM
Data from key trials will aid in increasing scientific understanding of ESUS and CVT RESPECT-ESUS is first randomised trial to investigate clinical profile of Pradaxa® vs ASA INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Inge

Business Wire Australia and New Zealand

Heart Center Dresden to Be First Commercial Clinical Site for Imricor

11-Oct-2018 4:26 PM
Imricor achieves commercial milestone with first customer contract Dr. Christopher Piorkowski in the newly installed iCMR lab at the Heart Center Dresden. (Photo: Heart Center Dresden) MINNEAPOLIS--(BUSINESS WIRE)--Imricor announced tod

Business Wire Australia and New Zealand

WellSky and Digi-Trax Partner to Power Safer and More Efficient Cellular Therapy Management

11-Oct-2018 11:08 AM
Collaboration Provides Clients with Seamless Compliance, Processing, and Labeling LENEXA, Kan.--(BUSINESS WIRE)--WellSky, a leading health and community care technology company backed by TPG Capital, and Digi-Trax Corporation, a glob

Business Wire Australia and New Zealand

Mario G. Pennisi, Australian Life Sciences Industry Leader, Joins Elo-Australia as Resident Director

11-Oct-2018 10:04 AM
Mario G. Pennisi joins Elo Life Systems as Resident Director of Elo-Australia (Photo: Business Wire) RESEARCH TRIANGLE PARK, N.C. & BRISBANE, Australia--(BUSINESS WIRE)--Elo Life Systems Inc. announced today that Mario G. Penni

Business Wire Australia and New Zealand

Westwater Resources to Present at Benchmark Mineral Intelligence’s ‘Graphite + Anodes 2018’ Conference

11-Oct-2018 9:10 AM
CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (“Westwater” or the “Company”) (Nasdaq: WWR) is pleased to announce that President and Chief Executive Officer, Christopher M. Jones will be presenting a

Business Wire Australia and New Zealand

New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018

11-Oct-2018 9:06 AM
Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12-month data from SUNBEAM™ pivotal trial In separate post hoc analysis of pooled data from phase 3 RADIANCE™ Part B and SUNBEAM trials, ozanimod reduced ann

Business Wire Australia and New Zealand

New analysis estimates the positive impact of empagliflozin on prolonging life expectancy in adults with type 2 diabetes and established cardiovascular disease

11-Oct-2018 8:58 AM
  Survival estimates from the EMPA-REG OUTCOME® trial data demonstrate potential long-term benefit of empagliflozin (marketed as Jardiance®) on life expectancy of adults with type 2 diabetes and cardiovascular disease1

Business Wire Australia and New Zealand

Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing

11-Oct-2018 8:35 AM
Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing (Photo: Business Wire) OXFORD, England--(BUSINESS WIRE)--MinIT, a rapid analysis and device control accessory for nanopore DN

Royal Flying Doctor Service

Flying Doctor Calls for Action to Halt Suicide Trend

10-Oct-2018 9:38 AM
Suicide rates are at a ten-year high and action is needed. This World Mental Health Day is an opportunity to look at the facts and take action: • Suicide is the leading cause of death among people aged 15-44 • 3,128 people died from intentional self-harm in 2017 • Suicide rates have risen 9.1% from 2016 to 2017

Business Wire Australia and New Zealand

Intelligent Fingerprinting: Fingerprint Drug Screen Test Works on the Living and Deceased

09-Oct-2018 9:49 AM
Journal of Analytical Toxicology study confirms how revolutionary drug test can detect four classes of drugs of abuse in just 10 minutes Coroners use test to detect drugs in fingerprint sweat samples taken in mortuaries SYDNEY & CAM